My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

NovoCure Limited - Ordinary Shares (NQ:NVCR)

11.46 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

3 Things About NovoCure That Smart Investors Know ↗

September 19, 2023

Its cancer-treating device is struggling to find its market.

Via The Motley Fool

Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer

September 08, 2023

From Novocure

Via Business Wire

3 Healthcare Stocks to Sell in September Before They Crash & Burn ↗

September 06, 2023

The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse.

Via InvestorPlace

Down 31% in 1 Day, What's Next for NovoCure Stock? ↗

September 04, 2023

It's entering a risky period, but it could persevere.

Via The Motley Fool

Why Novocure Stock Fell 24.4% This Week ↗

August 31, 2023

Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment.

Via The Motley Fool

What 11 Analyst Ratings Have To Say About NovoCure ↗

August 29, 2023

Via Benzinga

Why NovoCure Stock Is Crashing Today ↗

August 28, 2023

The company disappointed investors with its latest clinical trial update.

Via The Motley Fool

Is NovoCure's Stock Headed for a Free Fall? ↗

August 31, 2023

It can be hard to find a reason to remain bullish on NovoCure.

Via The Motley Fool

Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

August 29, 2023

From Novocure

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

August 29, 2023

On Tuesday, 99 stocks hit new 52-week lows.

Via Benzinga

What's Going On With NovoCure Stock Today? ↗

August 29, 2023

NovoCure Limited (NASDAQ: NVCR) shares are trading higher Tuesday. The stock appears to be recovering from a loss of over 30% on Monday. What To Know:

Via Benzinga

PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday ↗

August 29, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Dow Gains Over 100 Points; Hawaiian Electric Shares Surge ↗

August 28, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 34,490.80 while the NASDAQ rose 0.62% to 13,674.49. The S&P 500,...

Via Benzinga

Topics Stocks

Why Is Novocure (NVCR) Stock Down 30% Today? ↗

August 28, 2023

Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns.

Via InvestorPlace

Why Is Cancer Focused-Novocure's Stock Plunging Today? ↗

August 28, 2023

Novocure Ltd (NASDAQ: NVCR) shares are falling after the company's phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial of Tumor Treating Fields (TTFields) together with paclitaxel in patients...

Via Benzinga

Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 28, 2023

Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 28, 2023

Via Benzinga

Crude Oil Rises; GD Culture Group Shares Spike Higher ↗

August 28, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 150 points on Monday. The Dow traded up 0.46% to 34,505.54 while the NASDAQ rose 0.43% to 13,649.27. The S&P 500, also...

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 ↗

August 28, 2023

Via Benzinga

US Stocks Open Higher; Kimco Realty To Acquire RPT Realty ↗

August 28, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 250 points on Monday. Following the market opening Monday, the Dow traded up 0.81% to 34,626.22 while the NASDAQ rose 0.61% to...

Via Benzinga

Topics Stocks

Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer ↗

August 28, 2023

The company tested a regimen of chemotherapy and its tumor-treating fields.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 28, 2023

Via Benzinga

Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian Cancer

August 28, 2023

From Novocure

Via Business Wire

Could NovoCure Stock Help You Become a Millionaire? ↗

August 25, 2023

The stock has some significant upside, but it also comes with considerable risks and volatility.

Via The Motley Fool

Novocure to Participate in Upcoming Investor Conferences

August 25, 2023

From Novocure

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)

August 17, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

NOVOCURE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm

August 16, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Calling All NovoCure Limited (NVCR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit

August 16, 2023

New York, New York - Attorney Advertising – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action

Via Law Firm Newswire

Topics Lawsuit

NOVOCURE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against NovoCure Limited - NVCR

August 15, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

NVCR FINAL DEADLINE ALERT: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR

August 14, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.